Combined Shoulder Anterior Capsule and Suprascapular Nerve Block Versus Interscalene Block in Shoulder Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Shoulder Pain
Interventions
OTHER

suprascapular nerve block with 10 ml bupivacaine 0.25% & shoulder anterior capsule block with 30 ml bupivacaine 0.25%

postoperative analgesic effect of combined shoulder anterior capsule (SHAC) block with suprascapular nerve block (SSNB) following shoulder surgery by ultrasound guided suprascapular nerve block (SSNB) with 10 ml bupivacaine 0.25% deep to the transverse scapular ligament and Shoulder anterior capsule (SHAC) block with 30 ml bupivacaine 0.25% (20 ml deep to the deltoid muscle between the deltoid and subscapularis tendon \&10mL in the pericapsular space)

OTHER

Interscalene block with 20 ml bupivacaine 0.25%

postoperative analgesic effect of Interscalene block (ISB) following shoulder surgery by ultrasound guided interscalene brachial plexus block (ISB) with 20 ml bupivacaine 0.25% around C5-C6-C7 nerve roots of the brachial plexus

All Listed Sponsors
lead

Assiut University

OTHER

NCT06519851 - Combined Shoulder Anterior Capsule and Suprascapular Nerve Block Versus Interscalene Block in Shoulder Surgery | Biotech Hunter | Biotech Hunter